ADHD App Cleared; Anti-Inflammatories for Depression; Charges Over Adderall Scripts

(MedPage Today) — The FDA cleared a prescription smartphone app, dubbed LumosityRx, to help improve attention in adults with attention deficit-hyperactivity disorder (ADHD), maker Lumos Labs announced.
Teva Pharmaceutical submitted its once-monthly…